Literature DB >> 16120387

Oxidative stress and mitochondrial DNA repair: implications for NRTIs induced DNA damage.

Kazunari Hashiguchi1, Vilhelm A Bohr, Nadja C de Souza-Pinto.   

Abstract

Nucleotide analogue reverse transcriptase inhibitors (NRTI) can be incorporated into mitochondrial DNA (mtDNA), leading to mtDNA depletion and deletions. This is accompanied by elevated mitochondrial oxidative stress, which can cause accumulation of oxidative DNA lesions. Oxidized DNA damage is removed by the base excision repair (BER) pathway, by the sequential action of a DNA glycosylase, an Apurinic/Apyrimidinic endonuclease, DNA polymerase and DNA ligase. Mitochondria are very proficient in BER and various DNA glycosylases have been identified. DNA polymerase gamma is also involved in mitochondrial BER. In addition, there is growing evidence that mammalian mitochondria also possess mismatch repair activity.

Entities:  

Year:  2004        PMID: 16120387     DOI: 10.1016/j.mito.2004.05.014

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  9 in total

1.  Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells.

Authors:  Young-Mi Go; Thomas R Ziegler; Jennifer M Johnson; Li Gu; Jason M Hansen; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2006-11-10       Impact factor: 7.376

2.  Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementia.

Authors:  Wycliffe O Opii; Rukhsana Sultana; Hafiz Mohmmad Abdul; Mubeen Ahmad Ansari; Avindra Nath; D Allan Butterfield
Journal:  Exp Neurol       Date:  2006-10-25       Impact factor: 5.330

3.  Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.

Authors:  Berna Somuncu; Aysegul Ekmekcioglu; Fatma Merve Antmen; Tugce Ertuzun; Emre Deniz; Nazli Keskin; Joon Park; Ilgu Ece Yazici; Busra Simsek; Batu Erman; Whitney Yin; Burak Erman; Meltem Muftuoglu
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

Review 4.  Mitochondrial DNA, base excision repair and neurodegeneration.

Authors:  Nadja C de Souza-Pinto; David M Wilson; Tinna V Stevnsner; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2008-05-16

5.  Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1.

Authors:  Salina M Torres; Dale M Walker; Consuelo L McCash; Meghan M Carter; Jessica Ming; Edmund M Cordova; Rachel M Pons; Dennis L Cook; Steven K Seilkop; William C Copeland; Vernon E Walker
Journal:  Environ Mol Mutagen       Date:  2009-01       Impact factor: 3.216

6.  p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration.

Authors:  Matthew J Geden; Selena E Romero; Mohanish Deshmukh
Journal:  Cell Death Dis       Date:  2021-01-20       Impact factor: 8.469

7.  Arginine methylation of APE1 promotes its mitochondrial translocation to protect cells from oxidative damage.

Authors:  Yilan Zhang; Qi Zhang; LuLu Li; Dan Mu; Ke Hua; Shusheng Ci; Lei Shen; Li Zheng; Binghui Shen; Zhigang Guo
Journal:  Free Radic Biol Med       Date:  2020-07-15       Impact factor: 7.376

8.  Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Authors:  Mariana Gerschenson; Courtney Kim; Baiba Berzins; Babafemi Taiwo; Daniel E Libutti; Julia Choi; Diana Chen; Jill Weinstein; Jessica Shore; Barbara da Silva; Elizabeth Belsey; Grace A McComsey; Robert L Murphy
Journal:  J Antimicrob Chemother       Date:  2009-03-25       Impact factor: 5.758

Review 9.  DNA mismatch repair and oxidative DNA damage: implications for cancer biology and treatment.

Authors:  Gemma Bridge; Sukaina Rashid; Sarah A Martin
Journal:  Cancers (Basel)       Date:  2014-08-05       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.